SPRUCE BIOSCIENCES, INC. (SPRB)
Nasdaq · Pharmaceutical Preparations · Inc. DE
What they're doing
Between 2026-06-21 and 2026-09-19, public records show 1 signal for SPRUCE BIOSCIENCES, INC.. Most notable: 2026-07-27: Filed 8-K disclosing director or officer change. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-09-19 from public records.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement, director or officer change
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing material agreement
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-30 | Szwarcberg Javier B. | director | A | 266 | 4.53 | $1,205 |
| 2025-12-31 | Szwarcberg Javier B. | director | A | 4,690 | 4.53 | $21,246 |
| 2025-12-31 | Szwarcberg Javier B. | director | A | 4,690 | 4.53 | $21,248 |
| 2025-12-15 | Gharib Samir M. | officer | M | 496 | 0 | $0 |
| 2025-12-15 | Gharib Samir M. | officer | F | 178 | 80.67 | $14,359 |
| 2025-12-15 | Gharib Samir M. | officer | M | 513 | 0 | $0 |
| 2025-12-15 | Gharib Samir M. | officer | F | 184 | 80.67 | $14,843 |
| 2025-12-15 | Szwarcberg Javier B. | director | F | 752 | 80.67 | $60,664 |
| 2025-12-15 | Szwarcberg Javier B. | director | F | 608 | 80.67 | $49,047 |
| 2025-12-15 | Szwarcberg Javier B. | director | M | 1,480 | 0 | $0 |
| 2025-12-15 | Szwarcberg Javier B. | director | M | 1,196 | 0 | $0 |
| 2025-12-15 | Gharib Samir M. | officer | M | 496 | 0 | $0 |
| 2025-12-15 | Gharib Samir M. | officer | F | 178 | 80.67 | $14,359 |
| 2025-12-15 | Gharib Samir M. | officer | M | 513 | 0 | $0 |
| 2025-12-15 | Gharib Samir M. | officer | F | 184 | 80.67 | $14,843 |
| 2025-12-15 | Szwarcberg Javier B. | director | M | 1,480 | 0 | $0 |
| 2025-12-15 | Szwarcberg Javier B. | director | F | 752 | 80.67 | $60,664 |
| 2025-12-15 | Szwarcberg Javier B. | director | M | 1,196 | 0 | $0 |
| 2025-12-15 | Szwarcberg Javier B. | director | F | 608 | 80.67 | $49,047 |
| 2025-12-11 | Ways Douglas Kirk | director | M | 1,250 | 0 | $0 |
| 2025-12-11 | Gharib Samir M. | officer | M | 1,900 | 0 | $0 |
| 2025-12-11 | Gharib Samir M. | officer | F | 680 | 88.41 | $60,119 |
| 2025-12-11 | Szwarcberg Javier B. | director | F | 2,194 | 88.41 | $193,972 |
| 2025-12-11 | Szwarcberg Javier B. | director | M | 4,950 | 0 | $0 |
| 2025-12-11 | Ways Douglas Kirk | director | M | 1,250 | 0 | $0 |
| 2025-12-11 | Gharib Samir M. | officer | M | 1,900 | 0 | $0 |
| 2025-12-11 | Gharib Samir M. | officer | F | 680 | 88.41 | $60,119 |
| 2025-12-11 | Szwarcberg Javier B. | director | M | 4,950 | 0 | $0 |
| 2025-12-11 | Szwarcberg Javier B. | director | F | 2,194 | 88.41 | $193,972 |
| 2025-12-10 | Gharib Samir M. | officer | M | 514 | 0 | $0 |
| 2025-12-10 | Gharib Samir M. | officer | F | 184 | 85.67 | $15,763 |
| 2025-12-10 | Szwarcberg Javier B. | director | F | 428 | 85.67 | $36,667 |
| 2025-12-10 | Szwarcberg Javier B. | director | M | 1,196 | 0 | $0 |
| 2025-12-10 | Gharib Samir M. | officer | M | 514 | 0 | $0 |
| 2025-12-10 | Gharib Samir M. | officer | F | 184 | 85.67 | $15,763 |
| 2025-12-10 | Szwarcberg Javier B. | director | M | 1,196 | 0 | $0 |
| 2025-12-10 | Szwarcberg Javier B. | director | F | 428 | 85.67 | $36,667 |
| 2025-10-20 | Gharib Samir M. | officer | M | 2,053 | 0 | $0 |
| 2025-10-20 | Gharib Samir M. | officer | F | 661 | 148.16 | $97,934 |
| 2025-10-20 | Szwarcberg Javier B. | director | M | 4,784 | 0 | $0 |
| 2025-10-20 | Szwarcberg Javier B. | director | F | 1,539 | 148.16 | $228,018 |
| 2025-10-20 | Gharib Samir M. | officer | M | 2,053 | 0 | $0 |
| 2025-10-20 | Gharib Samir M. | officer | F | 661 | 148.16 | $97,934 |
| 2025-10-20 | Szwarcberg Javier B. | director | M | 4,784 | 0 | $0 |
| 2025-10-20 | Szwarcberg Javier B. | director | F | 1,539 | 148.16 | $228,018 |
| 2025-10-06 | Parkman Healthcare Partners LLC | ten percent owner | S | 232 | 19.33 | $4,485 |
| 2025-10-06 | Parkman Healthcare Partners LLC | ten percent owner | P | 256 | 17.91 | $4,585 |
| 2025-10-06 | Parkman Healthcare Partners LLC | ten percent owner | S | 25 | 17.46 | $437 |
| 2025-10-06 | Parkman Healthcare Partners LLC | ten percent owner | S | 232 | 19.33 | $4,485 |
| 2025-10-06 | Parkman Healthcare Partners LLC | ten percent owner | S | 25 | 17.46 | $437 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.
Recent filings
- 2026-08-14 SCHEDULE 13G
- 2026-08-14 SCHEDULE 13G/A
- 2026-08-14 SCHEDULE 13G/A
- 2026-08-14 SCHEDULE 13G
- 2026-08-12 10-Q
- 2026-08-12 8-K
- 2026-08-04 SCHEDULE 13G/A
- 2026-07-29 4
- 2026-07-29 3
- 2026-07-27 SCHEDULE 13G
- 2026-07-27 8-K
- 2026-07-09 4
- 2026-05-26 4
- 2026-05-26 4
- 2026-05-26 4
- 2026-05-26 4
- 2026-05-26 4
- 2026-05-26 8-K
- 2026-05-15 SCHEDULE 13G/A
- 2026-05-15 SCHEDULE 13G/A